In this webinar for patients and caregivers interested in learning about cancer immunotherapy, our invited expert, Dr. James P. Allison, discusses ways he and others are circumventing cancer's ability to evade the immune system through a treatment approach called immune checkpoint blockade.
James P. Allison, Ph.D., is the Vivian L. Smith Distinguished Chair in Immunology, Executive Director of the Immunotherapy Platform, and Director of the Parker Institute for Cancer Immunotherapy at The University of Texas MD Anderson Cancer Center in Houston, TX. Since 2011, he has served as director of the Cancer Research Institute Scientific Advisory Council.
The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, with additional support from Regeneron, Sanofi Genzyme, and Adaptimmune.
